Clinical trial
Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency
NCT00004801 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004801 |
|---|---|
| Title | Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | University of North Carolina |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hemophilia B, Factor IX Deficiency |
| Intervention type | Drug |
| Interventions | monoclonal factor IX replacement therapy |
| Enrollment | 3 |
| Start date | Mar 1, 1992 |
| First posted | Feb 25, 2000 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: